Literature DB >> 20702130

FMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patients.

D A Hall1, D Jennings, J Seibyl, F Tassone, K Marek.   

Abstract

PURPOSE: To determine if patients with parkinsonism and fragile X mental retardation 1 (FMR1) gene expansions have a striatal dopamine deficit similar to Parkinson disease (PD) patients. SCOPE: The authors studied three patients with parkinsonism carrying small expansions in the FMR1 gene (41-60 CGG) with [(123)I]β-CIT SPECT imaging. The patients responded to dopaminergic medications, but had preserved dopamine transporter density.
CONCLUSIONS: These results suggest that parkinsonism associated with smaller FMR1 expansions may be related to mechanisms other than pre-synaptic dopaminergic changes and may represent a potential explanation for at least some parkinsonian cases with scans without evidence of dopaminergic deficits (SWEDD).
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702130      PMCID: PMC2963704          DOI: 10.1016/j.parkreldis.2010.07.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  10 in total

1.  Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease.

Authors: 
Journal:  Neurology       Date:  2007-09-19       Impact factor: 9.910

2.  Clinical involvement and protein expression in individuals with the FMR1 premutation.

Authors:  F Tassone; R J Hagerman; A K Taylor; J B Mills; S W Harris; L W Gane; P J Hagerman
Journal:  Am J Med Genet       Date:  2000-03-13

3.  Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

Authors:  M Laruelle; E Wallace; J P Seibyl; R M Baldwin; Y Zea-Ponce; S S Zoghbi; J L Neumeyer; D S Charney; P B Hoffer; R B Innis
Journal:  J Cereb Blood Flow Metab       Date:  1994-11       Impact factor: 6.200

4.  Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats.

Authors:  Danuta Z Loesch; Quang M Bui; Richard M Huggins; Robert J Mitchell; Randi J Hagerman; Flora Tassone
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

5.  Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers.

Authors:  R Ceravolo; A Antonini; D Volterrani; C Rossi; S Goldwurm; E Di Maria; L Kiferle; U Bonuccelli; L Murri
Journal:  Neurology       Date:  2005-12-27       Impact factor: 9.910

Review 6.  Does levodopa slow or hasten the rate of progression of Parkinson's disease?

Authors:  Stanley Fahn
Journal:  J Neurol       Date:  2005-10       Impact factor: 4.849

7.  Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease.

Authors:  Deborah A Hall; Katherine Howard; Randi Hagerman; Maureen A Leehey
Journal:  Parkinsonism Relat Disord       Date:  2008-06-20       Impact factor: 4.891

8.  (123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis.

Authors:  Danna L Jennings; John P Seibyl; David Oakes; Shirley Eberly; John Murphy; Ken Marek
Journal:  Arch Neurol       Date:  2004-08

9.  Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.

Authors:  R B Innis; J P Seibyl; B E Scanley; M Laruelle; A Abi-Dargham; E Wallace; R M Baldwin; Y Zea-Ponce; S Zoghbi; S Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.

Authors:  Sébastien Jacquemont; Randi J Hagerman; Maureen A Leehey; Deborah A Hall; Richard A Levine; James A Brunberg; Lin Zhang; Tristan Jardini; Louise W Gane; Susan W Harris; Kristin Herman; James Grigsby; Claudia M Greco; Elizabeth Berry-Kravis; Flora Tassone; Paul J Hagerman
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

  10 in total
  9 in total

Review 1.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

2.  Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females.

Authors:  Danuta Z Loesch; Flora Tassone; George D Mellick; Malcolm Horne; Justin P Rubio; Minh Q Bui; David Francis; Elsdon Storey
Journal:  Mov Disord       Date:  2018-07       Impact factor: 10.338

3.  Early abnormalities in 123I-ioflupane (DaTSCAN) imaging in the fragile X-associated tremor ataxia syndrome (FXTAS): a case report.

Authors:  G Madeo; F Alemseged; B Di Pietro; O Schillaci; A Pisani
Journal:  Neurol Sci       Date:  2012-10-18       Impact factor: 3.307

4.  Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series.

Authors:  Sarah M Debrey; Maureen A Leehey; Olga Klepitskaya; Christopher M Filley; Raj C Shah; Benzi Kluger; Elizabeth Berry-Kravis; Elaine Spector; Flora Tassone; Deborah A Hall
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

5.  Cardiac sympathetic denervation in Parkinson's disease patients with SWEDDs.

Authors:  Wooyoung Jang; Joong-Seok Kim; Jin Whan Cho; Young Hwan Kim; Ji Young Kim; Yun Young Choi; Hee-Tae Kim
Journal:  Neurol Sci       Date:  2012-11-24       Impact factor: 3.307

6.  Fragile x-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment.

Authors:  Deborah A Hall; Joan A O'keefe
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-05-11

7.  Clinical Differentiation of Essential Tremor and Parkinson's Disease.

Authors:  Robert Fekete; Jin Li
Journal:  Clin Med Insights Case Rep       Date:  2013-04-29

8.  Parkinsonism Versus Concomitant Parkinson's Disease in Fragile X-Associated Tremor/Ataxia Syndrome.

Authors:  María Jimena Salcedo-Arellano; Marisol Wendy Wolf-Ochoa; Tiffany Hong; Sarwat Amina; Flora Tassone; Mirna Lechpammer; Randi Hagerman; Verónica Martínez-Cerdeño
Journal:  Mov Disord Clin Pract       Date:  2020-04-09

9.  Clinical differentiation of essential tremor and Parkinson's disease.

Authors:  Robert Fekete; Jin Li
Journal:  Clin Med Insights Case Rep       Date:  2013-04-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.